Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | AMG 330 |
Trade Name | |
Synonyms | AMG330|AMG-330|Eluvixtamab |
Drug Descriptions |
AMG 330 (Eluvixtamab) is a bispecific antibody that targets both CD33 and CD3, resulting in cytotoxic activity against CD33-positive cells (PMID: 24674885, PMID: 30396365). |
DrugClasses | CD3 Antibody 97 CD33 Antibody 13 |
CAS Registry Number | 1679391-73-1 |
NCIT ID | C123332 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AMG 330 | AMG 330 | 0 | 1 |
AMG 330 + Pembrolizumab | AMG 330 Pembrolizumab | 0 | 1 |